Photo: Pexels
Cancer is the leading cause of death among noncitizen residents of the United States. Not heart disease. Not diabetes. Cancer.
That fact should stop every health system leader in their tracks. A landmark study published this month in JAMA Network Open makes it more alarming: noncitizens are being screened for the three most preventable cancers at rates dramatically below their US-born neighbors — and the gap is almost entirely structural, not cultural.
This is not a story about patients who don't want screening. It is a story about a system not designed to reach them.
The Study
Researchers analyzed 131,501 respondents from the National Health Interview Survey (NHIS) spanning 2010 to 2023 — the largest citizenship-stratified cancer screening analysis in the peer-reviewed literature. The study was published August 3, 2026 in JAMA Network Open (PMID: 42574011). Findings are nationally representative and adjusted for demographics, socioeconomic status, insurance coverage, and healthcare access factors.
Colorectal cancer screening: 43.6% of noncitizens vs. 75.5% of US-born adults
The colorectal cancer screening disparity is the most striking finding. A 32-percentage-point gap separates noncitizen and US-born adults. The adjusted odds ratio of 0.35 means noncitizens are less than one-third as likely to be up to date on CRC screening after controlling for all measured confounders.
The Numbers
Colorectal cancer: 43.6% noncitizens vs. 75.5% US-born (adjusted OR 0.35, 95% CI 0.32-0.38)
Cervical cancer: 57.1% noncitizens vs. 71.6% US-born women (adjusted OR 0.41, 95% CI 0.38-0.44)
Breast cancer: 73.0% noncitizens vs. 80.1% US-born women (adjusted OR 0.57, 95% CI 0.52-0.62)
Every one of these cancers is more detectable, more treatable, and less deadly when caught early. Every percentage point of that gap represents preventable mortality.
Cancer screening rates by citizenship status — three-cancer comparison
The Mediation Analysis: This Is a System Problem
The researchers did not stop at documenting the gap. They performed a formal mediation analysis to quantify how much of each disparity is explained by socioeconomic factors and healthcare access barriers: insurance status, usual care source, language barriers, financial hardship, and geography.
Results:
Breast cancer: 97.1% of the disparity is explained by structural barriers
Colorectal cancer: 56.6% of the disparity is explained by structural barriers
Cervical cancer: 39.6% of the disparity is explained by structural barriers
97.1% of the breast cancer screening disparity is structural
Nearly the entire breast cancer screening gap between noncitizen and US-born women is explained by structural factors — not preferences, not culture, not anything inherent to the patient population. Insurance and access explain the gap. Insurance and access can close it.
For colorectal and cervical cancer, a meaningful residual remains unexplained by measured factors. This residual likely reflects unmeasured barriers: fear of immigration consequences, documentation concerns, distrust of the medical system. These require different interventions — community trust-building, promotora programs, and CHW integration.
What the mediation analysis rules out definitively is the comfortable narrative that noncitizens don't prioritize screening. The data does not support that story. The data supports one conclusion: the system is failing them.
Who Benefits When the Gap Closes?
This is not just an equity story. It is a business case.
Health system winners and losers when screening gaps close
Late-stage cancer diagnosis is expensive. Stage IV colorectal cancer costs four to five times more to treat than Stage I. When noncitizens fall through the screening gap, they present at emergency departments with advanced disease — and the cost is absorbed by safety-net hospitals, Medicaid, and the broader system.
Integrated health systems and payers with large immigrant-serving populations have a direct financial interest in closing this gap. Earlier detection drives better outcomes, reduces total cost of care, and improves the quality metrics that increasingly drive value-based reimbursement. The ROI on screening navigation for underserved populations is well-documented in the literature — the question is whether health systems have the operational infrastructure to capture it.
Cancer screening rate comparison — grouped bar chart
A 5-Step Playbook for FQHCs and Immigrant-Serving Providers
Federally Qualified Health Centers are on the front lines of this disparity. Here is a concrete operational framework:
5-step FQHC screening equity playbook
1. Screen for the screeners. Use SDOH tools (AHC-HRSN or equivalent) at every visit to document barriers: insurance, language, transportation, cost. Identify patients who need navigation, not just reminders.
2. Deploy culturally concordant navigation. Patient navigators who share language and cultural background improve screening uptake significantly. FIT completion for CRC responds especially well to structured navigation. Budget for dedicated FTE — this is not a volunteer program.
3. Address practical barriers. Transport vouchers. Evening and weekend hours. On-site FIT kit distribution rather than referral-dependent pathways. Sliding-scale pricing regardless of immigration status. These are operational decisions, not clinical ones.
4. Partner with CHWs and promotoras. Community health workers embedded in trusted institutions — churches, schools, community centers — reach patients before crisis. For communities where distrust of the medical system is documented, CHWs are the bridge that institutional outreach cannot replicate.
5. Track and report equity metrics. Almost no health system quality dashboard stratifies screening rates by citizenship or immigration status. They should. Aggregate rates meeting national benchmarks can mask catastrophic underperformance in specific subpopulations. What gets measured, gets managed.
Cancer-Specific Clinical Considerations
Colorectal cancer: FIT (fecal immunochemical test) is underutilized in this context. It is non-invasive, requires no bowel prep, is available in multiple languages, and can be completed at home. Practices defaulting to colonoscopy referral as the primary CRC screening pathway may be widening the gap through referral friction alone. FIT-first pathways are guideline-concordant and practically superior for this population.
Cervical cancer: The cervical screening gap is most strongly mediated by uninsurance and lack of a usual care source. Self-sampling HPV tests offer promise for reaching noncitizen women who avoid clinic settings. Integrating cervical screening into prenatal, WIC, and family planning visits increases opportunistic screening rates substantially.
Breast cancer: The 97.1% structural mediation means the clinical conversation is less about patient counseling and more about system design. Mobile mammography units, partnerships with employers in high-immigrant-workforce sectors, and insurance navigation services address the actual drivers of this disparity.
The Policy Dimension
The Affordable Care Act expanded coverage dramatically but explicitly excluded undocumented immigrants. Legal permanent residents face a 5-year Medicaid waiting period in most states. Until federal policy catches up, the burden falls on health systems and safety-net providers. The study's findings support a clear agenda:
Enhanced federal FQHC reimbursement for immigrant-serving practices with documented navigation programs
State-level Medicaid expansions to cover undocumented immigrants
Mandating SDOH screening documentation in Medicaid managed care contracts
Requiring citizenship-stratified screening rate reporting in HEDIS measures
The Bottom Line
This study moves the conversation from knowing that noncitizens have lower screening rates to understanding why — with enough precision to design targeted interventions.
For breast cancer, the near-total structural attribution is a mandate. The gap is not a mystery and it is not inevitable. It is the predictable output of a system designed without this population in mind.
For colorectal cancer, the 43% unexplained residual calls for deeper community-centered research and engagement. The structural half is addressable immediately.
Health systems that serve significant immigrant populations — in most major metropolitan areas, that means most health systems — need to ask one direct question: is our cancer screening infrastructure designed for the patients we actually serve?
Cancer doesn't check papers. The healthcare system's job is to make sure it doesn't need to.
Source: JAMA Network Open. 2026 Aug 3;9(8):e2628371. PMID: 42574011.
Oatmeal Health publishes weekly evidence briefs on cancer screening, health equity, and healthcare delivery. Subscribe here.